{"contacts": [{"terms": [{"accession": "MS:1000586", "name": "contact name", "value": "Dingyin Tao"}, {"accession": "MS:1000589", "name": "contact email", "value": "dingyin.tao@nih.gov"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS)"}, {"accession": "MS:1002037", "name": "dataset submitter"}]}, {"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "Dingyin Tao"}, {"accession": "MS:1000589", "name": "contact email", "value": "dingyin.tao@nih.gov"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "NIH NCATS"}]}], "datasetFiles": [{"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/04/PXD024074/Sample_BM_1uL01.d.zip"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/04/PXD024074/Sample_Ce_1uL01.d.zip"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/04/PXD024074/Sample_Di_1uL01.d.zip"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/04/PXD024074/Sample_LLEc_1uL01.d.zip"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/04/PXD024074/Sample_NebEc_1uL01.d.zip"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/04/PXD024074/Sample_Ov_1uL01.d.zip"}, {"accession": "MS:1002850", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/04/PXD024074/Sample_BM_1uL01.mgf"}, {"accession": "MS:1002850", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/04/PXD024074/Sample_Ce_1uL01.mgf"}, {"accession": "MS:1002850", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/04/PXD024074/Sample_Di_1uL01.mgf"}, {"accession": "MS:1002850", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/04/PXD024074/Sample_LLEc_1uL01.mgf"}, {"accession": "MS:1002850", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/04/PXD024074/Sample_NebEc_1uL01.mgf"}, {"accession": "MS:1002850", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/04/PXD024074/Sample_Ov_1uL01.mgf"}, {"accession": "MS:1002848", "name": "Result file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/04/PXD024074/Sample_BM_1uL01.mzid.gz"}, {"accession": "MS:1002848", "name": "Result file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/04/PXD024074/Sample_CLLEc_1uL01.mzid.gz"}, {"accession": "MS:1002848", "name": "Result file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/04/PXD024074/Sample_Ce_1uL01.mzid.gz"}, {"accession": "MS:1002848", "name": "Result file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/04/PXD024074/Sample_NebEc_1uL01.mzid.gz"}, {"accession": "MS:1002848", "name": "Result file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/04/PXD024074/Sample_Ov_1uL01.mzid.gz"}, {"accession": "MS:1002848", "name": "Result file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/04/PXD024074/Sample_Di_1uL01.mzid.gz"}], "description": "The phylogenetic divergence between parasitic and mammalian phosphoglycerate mutases (PGMs) offers an opportunity for selective pharmacologic targeting of glycolysis in disease-causing organisms. With this aim we previously described ipglycermides, discovered by affinity selection from a vast nucleic acid-encoded cyclic peptide library, as the first potent and selective class of cofactor-independent PGM (iPGM) inhibitors. From C. elegans iPGM\u2022ipglycermide co-crystal structures we now delineate the previously hypothesized metal ion binding geometries at the ipglycermide C-terminal cysteine. To develop a baseline structure-activity relationship complementing the structural details, the 14 amino acids of ipglycermide were individually substituted creating 280 DNA-encoded analogs.  Binding affinities to immobilized C. elegans iPGM, measured as fold-enrichment by deep sequencing, illuminated the significance of each amino acid sidechain to the pharmacophore and guided ipglycermides designed with improved orthologous iPGM affinity.  In consideration with binding kinetics, we describe how the high affinity of ipglycermide to a range of iPGM orthologs is achieved by a co-dependence on tunable metal ion coordination-associated off-rates and induced-concavity around the macrocyclic core at the phosphotransferase-phosphatase domain interface to freeze the structurally dynamic enzyme into an inactive, stable complex.", "fullDatasetLinks": [{"accession": "MS:1002852", "name": "Dataset FTP location", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/04/PXD024074"}, {"accession": "MS:1001930", "name": "PRIDE project URI", "value": "http://www.ebi.ac.uk/pride/archive/projects/PXD024074"}], "identifiers": [{"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD024074"}, {"accession": "MS:1001922", "name": "Digital Object Identifier (DOI)", "value": "10.6019/PXD024074"}], "instruments": [{"accession": "MS:1002783", "name": "6550 iFunnel Q-TOF LC/MS"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "phosphoglycerate mutase, cyclic peptide, proteomics, structure, interaction"}], "modifications": [{"accession": "MOD:00397", "name": "iodoacetamide derivatized residue"}], "publications": [{"terms": [{"accession": "MS:1000879", "name": "PubMed identifier", "value": "33812994"}, {"accession": "MS:1002866", "name": "Reference", "value": "Wiedmann M, Dranchak PK, Aitha M, Queme B, Collmus CD, Kashipathy MM, Kanter L, Lamy L, Rogers JM, Tao D, Battaile KP, Rai G, Lovell S, Suga H, Inglese J. Structure-activity relationship of ipglycermide binding to phosphoglycerate mutases. J Biol Chem. 2021:100628"}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Escherichia coli"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "562"}]}, {"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Dirofilaria immitis"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "6287"}]}, {"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Caenorhabditis elegans"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "6239"}]}, {"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Onchocerca volvulus"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "6282"}]}, {"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Brugia malayi"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "6279"}]}], "title": "Co-dependent macrocyclic peptide interactions facilitate ipglycermide high affinity binding to phosphoglycerate mutases"}